éå»1ã¶æéã«Arcturus Therapeutics Holdings Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã12åã«åºã¥ãããŒã¿ã
仿ãARCTã¯6ä»¶ã®ãè²·ããã3ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããARCTã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯22.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.837ã«ç¶ããARCTã®FY2026Q3ã®EPSã¯-0.679ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.84 ã§ããããArcturus Therapeutics Holdings IncARCT ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.95 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.68 ãšäºæ³ãããŸãã